SI2121898T1 - Postopek za ohranitev virusnih delcev - Google Patents
Postopek za ohranitev virusnih delcevInfo
- Publication number
- SI2121898T1 SI2121898T1 SI200830486T SI200830486T SI2121898T1 SI 2121898 T1 SI2121898 T1 SI 2121898T1 SI 200830486 T SI200830486 T SI 200830486T SI 200830486 T SI200830486 T SI 200830486T SI 2121898 T1 SI2121898 T1 SI 2121898T1
- Authority
- SI
- Slovenia
- Prior art keywords
- viral particles
- polyethyleneimine
- preserving
- concentration
- preserving viral
- Prior art date
Links
- 239000002245 particle Substances 0.000 title abstract 4
- 230000003612 virological effect Effects 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 235000000346 sugar Nutrition 0.000 abstract 4
- 229920002873 Polyethylenimine Polymers 0.000 abstract 3
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 150000008163 sugars Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Jellies, Jams, And Syrups (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0705245.9A GB0705245D0 (en) | 2007-03-19 | 2007-03-19 | Stable biological products |
US91722007P | 2007-05-10 | 2007-05-10 | |
EP08718824A EP2121898B8 (en) | 2007-03-19 | 2008-03-19 | Method for preserving viral particles |
PCT/GB2008/000987 WO2008114021A1 (en) | 2007-03-19 | 2008-03-19 | Method for preserving viral particles |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2121898T1 true SI2121898T1 (sl) | 2012-02-29 |
Family
ID=38008686
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200830486T SI2121898T1 (sl) | 2007-03-19 | 2008-03-19 | Postopek za ohranitev virusnih delcev |
Country Status (18)
Country | Link |
---|---|
US (1) | US8313897B2 (sl) |
EP (1) | EP2121898B8 (sl) |
JP (1) | JP2010521961A (sl) |
KR (1) | KR20100015613A (sl) |
CN (1) | CN101636486A (sl) |
AT (1) | ATE525455T1 (sl) |
AU (1) | AU2008228086A1 (sl) |
BR (1) | BRPI0808960A2 (sl) |
CA (1) | CA2681182A1 (sl) |
DK (1) | DK2121898T3 (sl) |
ES (1) | ES2370675T3 (sl) |
GB (2) | GB0705245D0 (sl) |
HR (1) | HRP20110814T1 (sl) |
IL (1) | IL200671A0 (sl) |
PL (1) | PL2121898T3 (sl) |
RU (1) | RU2009138344A (sl) |
SI (1) | SI2121898T1 (sl) |
WO (1) | WO2008114021A1 (sl) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007079147A2 (en) | 2005-12-28 | 2007-07-12 | Advanced Bionutrition Corporation | A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
CA2673120C (en) | 2006-12-18 | 2012-08-07 | Advanced Bionutrition Corporation | A dry food product containing live probiotic |
CN102164943A (zh) * | 2008-09-24 | 2011-08-24 | 稳定技术有限公司 | 使用糖和聚乙烯亚胺保存多肽的方法 |
EP3266448B1 (en) | 2009-03-27 | 2022-02-16 | Intervet International B.V. | Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
JP5804453B2 (ja) * | 2009-05-14 | 2015-11-04 | 国立大学法人 東京大学 | 結晶性ポリオール微粒子及びその調製方法 |
CN102459568A (zh) | 2009-05-26 | 2012-05-16 | 先进生物营养公司 | 包含生物活性微生物和/或生物活性材料的稳定干粉组合物及其制造方法 |
SG182317A1 (en) * | 2010-01-28 | 2012-08-30 | Advanced Bionutrition Corp | Dry glassy composition comprising a bioactive material |
US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
GB201002419D0 (en) * | 2010-02-12 | 2010-03-31 | Isis Innovation | Stable live vaccine formulations |
AU2011234264B2 (en) * | 2010-03-31 | 2016-02-04 | Stabilitech Ltd | Excipients for stabilising viral particles, polypeptides or biological material |
JP5960120B2 (ja) | 2010-03-31 | 2016-08-02 | スタビリテック リミテッド | ウイルス粒子の安定化 |
CN102892409B (zh) | 2010-03-31 | 2015-12-09 | 稳定性科技有限公司 | 用于保存铝盐佐剂和铝盐-佐剂化疫苗的方法 |
RS57588B1 (sr) | 2010-08-13 | 2018-11-30 | Advanced Bionutrition Corp | Supstanca za stabilizaciju bioloških materijala za suvo skladištenje |
CN103347535B (zh) | 2010-12-02 | 2015-11-25 | 昂科利蒂克斯生物科技公司 | 液体病毒制剂 |
EA201390812A1 (ru) | 2010-12-02 | 2013-11-29 | Онколитикс Байотек Инк. | Лиофилизированные вирусные составы |
GB201117233D0 (en) | 2011-10-05 | 2011-11-16 | Stabilitech Ltd | Stabilisation of polypeptides |
TWI690322B (zh) | 2012-10-02 | 2020-04-11 | 法商傳斯堅公司 | 含病毒的調配物及其使用 |
GB201406569D0 (en) | 2014-04-11 | 2014-05-28 | Stabilitech Ltd | Vaccine compositions |
EP3169341B1 (en) | 2014-07-16 | 2019-06-05 | Transgene SA | Oncolytic virus for expression of immune checkpoint modulators |
WO2016131945A1 (en) | 2015-02-20 | 2016-08-25 | Transgene Sa | Combination product with autophagy modulator |
AU2016297986B8 (en) | 2015-07-29 | 2020-06-11 | Advanced Bionutrition Corp. | Stable dry probiotic compositions for special dietary uses |
WO2017035664A1 (en) | 2015-09-02 | 2017-03-09 | Mcmaster University | Enhanced thermal stability for adenoviral vectors through spray drying |
CA3023022A1 (en) | 2016-05-04 | 2017-11-09 | Transgene Sa | Combination therapy with cpg tlr9 ligand |
WO2018049261A1 (en) | 2016-09-09 | 2018-03-15 | Icellhealth Consulting Llc | Oncolytic virus expressing immune checkpoint modulators |
WO2018069316A2 (en) | 2016-10-10 | 2018-04-19 | Transgene Sa | Immunotherapeutic product and mdsc modulator combination therapy |
WO2018091680A1 (en) | 2016-11-18 | 2018-05-24 | Transgene Sa | Cowpox-based oncolytic vectors |
US11626228B2 (en) * | 2016-12-22 | 2023-04-11 | Rogers Corporation | Multi-layer magneto-dielectric material |
ES2905478T3 (es) | 2016-12-28 | 2022-04-08 | Transgene Sa | Virus oncolíticos y moléculas terapéuticas |
US10617756B2 (en) | 2017-01-05 | 2020-04-14 | Shimojani, LLC | Drug regimen for treatment of cerebral ischemia |
GB2562241B (en) | 2017-05-08 | 2022-04-06 | Stabilitech Biopharma Ltd | Vaccine compositions |
KR20240113607A (ko) | 2017-06-21 | 2024-07-22 | 트랜스진 | 개인 맞춤형 백신 |
WO2019020543A1 (en) | 2017-07-28 | 2019-01-31 | Transgene Sa | ONCOLYTIC VIRUSES EXPRESSING AGENTS TARGETING METABOLIC IMMUNE MODULATORS |
MX2020009262A (es) | 2018-03-07 | 2021-01-08 | Transgene | Vectores de parapoxvirus. |
WO2020011754A1 (en) | 2018-07-09 | 2020-01-16 | Transgene | Chimeric vaccinia viruses |
SG11202102876XA (en) * | 2018-09-28 | 2021-04-29 | Otsuka Pharma Factory Inc | Mammal cell preserving solution containing acarbose or stachyose |
EP3875119A4 (en) | 2018-10-30 | 2022-08-31 | The University of Tokyo | ONCOLYTIC VIRUS FOR THE TREATMENT OF CANCER |
SG11202106898VA (en) | 2018-12-28 | 2021-07-29 | Transgene Sa | M2-defective poxvirus |
WO2020136232A1 (en) | 2018-12-28 | 2020-07-02 | Transgene Sa | Immunosuppressive m2 protein |
CA3171097A1 (en) * | 2020-04-14 | 2021-10-21 | Federico Carlos Arejola Gaeta | Products and methods for detection of viral nucleic acid |
CA3189238A1 (en) | 2020-07-13 | 2022-01-20 | Transgene | Treatment of immune depression |
WO2022161502A1 (zh) | 2021-02-01 | 2022-08-04 | 羿尊生物医药(浙江)有限公司 | 一种靶向蛋白降解系统及其应用 |
EP4340874A1 (en) * | 2021-05-21 | 2024-03-27 | Takeda Vaccines, Inc. | Solid composition, freeze-drying method and glass vial |
CN113655057A (zh) * | 2021-08-24 | 2021-11-16 | 威世药业(如皋)有限公司 | 一种检测冷冻干燥处理对痘苗病毒毒力影响的设备 |
WO2023025899A2 (en) | 2021-08-26 | 2023-03-02 | Transgene | Delivery system for targeting genes of the interferon pathway |
CN114392237B (zh) * | 2021-12-28 | 2024-02-02 | 上海允英生物医药科技有限公司 | 一种冻干病毒制剂及其制备方法 |
WO2023213764A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf |
WO2023213763A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab |
WO2024003353A1 (en) | 2022-07-01 | 2024-01-04 | Transgene | Fusion protein comprising a surfactant-protein-d and a member of the tnfsf |
WO2024038175A1 (en) | 2022-08-18 | 2024-02-22 | Transgene | Chimeric poxviruses |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69735600T2 (de) * | 1997-11-26 | 2007-01-25 | Universal Preservation Technologies, Inc., San Diego | Konservierung empfindlicher biologischer proben durch verglasung |
CN1258379C (zh) | 2000-02-08 | 2006-06-07 | 阿勒根公司 | 肉毒杆菌毒素药物组合物 |
US20040110267A1 (en) * | 2000-12-15 | 2004-06-10 | Stratagene | Room temperature stable competent cells |
GB0502661D0 (en) * | 2005-02-09 | 2005-03-16 | Stabilitech Ltd | A desiccated product |
RU2396976C2 (ru) * | 2005-10-07 | 2010-08-20 | Пфайзер Продактс Инк. | Вакцины и способы лечения собачьего гриппа |
-
2007
- 2007-03-19 GB GBGB0705245.9A patent/GB0705245D0/en not_active Ceased
-
2008
- 2008-03-19 DK DK08718824.9T patent/DK2121898T3/da active
- 2008-03-19 RU RU2009138344/10A patent/RU2009138344A/ru not_active Application Discontinuation
- 2008-03-19 US US12/531,902 patent/US8313897B2/en not_active Expired - Fee Related
- 2008-03-19 EP EP08718824A patent/EP2121898B8/en not_active Not-in-force
- 2008-03-19 ES ES08718824T patent/ES2370675T3/es active Active
- 2008-03-19 AU AU2008228086A patent/AU2008228086A1/en not_active Abandoned
- 2008-03-19 AT AT08718824T patent/ATE525455T1/de active
- 2008-03-19 CA CA002681182A patent/CA2681182A1/en not_active Abandoned
- 2008-03-19 JP JP2009554082A patent/JP2010521961A/ja not_active Withdrawn
- 2008-03-19 KR KR1020097021553A patent/KR20100015613A/ko not_active Application Discontinuation
- 2008-03-19 CN CN200880008926A patent/CN101636486A/zh active Pending
- 2008-03-19 BR BRPI0808960-4A patent/BRPI0808960A2/pt not_active IP Right Cessation
- 2008-03-19 GB GB0915291A patent/GB2459611B/en not_active Expired - Fee Related
- 2008-03-19 PL PL08718824T patent/PL2121898T3/pl unknown
- 2008-03-19 SI SI200830486T patent/SI2121898T1/sl unknown
- 2008-03-19 WO PCT/GB2008/000987 patent/WO2008114021A1/en active Application Filing
-
2009
- 2009-09-01 IL IL200671A patent/IL200671A0/en unknown
-
2011
- 2011-11-02 HR HR20110814T patent/HRP20110814T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
IL200671A0 (en) | 2011-08-01 |
AU2008228086A1 (en) | 2008-09-25 |
HRP20110814T1 (hr) | 2012-01-31 |
KR20100015613A (ko) | 2010-02-12 |
US8313897B2 (en) | 2012-11-20 |
BRPI0808960A2 (pt) | 2014-08-26 |
EP2121898A1 (en) | 2009-11-25 |
EP2121898B8 (en) | 2012-02-15 |
PL2121898T3 (pl) | 2012-02-29 |
GB0705245D0 (en) | 2007-04-25 |
CN101636486A (zh) | 2010-01-27 |
GB2459611A (en) | 2009-11-04 |
JP2010521961A (ja) | 2010-07-01 |
RU2009138344A (ru) | 2011-04-27 |
CA2681182A1 (en) | 2008-09-25 |
EP2121898B1 (en) | 2011-09-21 |
US20100015177A1 (en) | 2010-01-21 |
GB2459611B (en) | 2011-02-16 |
ATE525455T1 (de) | 2011-10-15 |
WO2008114021A1 (en) | 2008-09-25 |
GB0915291D0 (en) | 2009-10-07 |
DK2121898T3 (da) | 2012-01-09 |
ES2370675T3 (es) | 2011-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2459611B (en) | Method for preserving viral particles | |
GB2479069A (en) | Method for preserving polypeptides using a sugar and polyethyleneimine | |
EP2727998A3 (en) | Methods for purifying pancreatic endoderm cells derived from human embryonic stem cells | |
WO2006070370A3 (en) | Stem cells culture systems | |
WO2006099258A8 (en) | Tigecycline compositions and methods of preparation | |
WO2009007852A3 (en) | Multipotent/pluripotent cells and methods | |
WO2009118253A3 (en) | Hair styling composition | |
WO2010028112A3 (en) | Quantum dots, methods of making quantum dots, and methods of using quantum dots | |
DK1898721T3 (da) | Fremgangsmåde til fremstilling af en vandig suspension og et pulverformigt præparat af et eller flere carotioider | |
AR054919A1 (es) | Atributos mejorados de un endofito de las gramineas | |
WO2006116622A3 (en) | Novel methods and devices for evaluating poisons | |
SG170751A1 (en) | Extractions and methods comprising elder species | |
WO2007050462A3 (en) | Method of treating silica and inkjet recording material | |
WO2010020910A3 (en) | Method for generating a cipher-based message authentication code | |
NO20080158L (no) | Oyedraper som inneholder roflumilast | |
IN2012DN05020A (sl) | ||
WO2010059433A3 (en) | Mems pressure and acceleration dosimeter | |
WO2007046890A8 (en) | Lozenge for treatment of dry mouth and related conditions | |
UA100394C2 (en) | Lipoic acid pellet composition | |
WO2007030674A3 (en) | Use of nucleases to improve viability and enhance transgene expression in transfected cells | |
WO2006088747A3 (en) | Serum-free reagents for the isolation, cultivation, and cryopreservation of postnatal pluripotent epiblast-like stem cells | |
WO2007019499A3 (en) | Nucleic acid sequences associated with cell states | |
WO2007138261A3 (en) | Modified sugar nucleotide | |
Iwata et al. | Measurements of the Gluon Polarization in the Nucleon at COMPASS | |
太田悠造 | Taxonomical studies on gnathiids (Crustacea, Isopoda, Gnathiidae) from Okinawa Islands, Japan |